Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibody syndromes.

A L Parke1

  • 1Division of Rheumatic Diseases, University of Connecticut School of Medicine, Farmington.

Rheumatic Diseases Clinics of North America
|May 1, 1989
PubMed
Summary

Antibodies to negatively charged phospholipids are linked to blood clots and pregnancy complications. Further research and standardized testing are crucial for understanding and managing this autoimmune syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sjögren's syndrome: History, clinical and pathological features.

Inflammopharmacology·2007
Same author

Multiple organ dysfunction syndrome.

Inflammopharmacology·2004
Same author

Antimalarial drugs in systemic lupus erythematosus: use in pregnancy.

Drug safety·2001
Same author

Toward optimal health: the experts discuss dry eye syndrome. Interview by Jodi Godfrey Meisler.

Journal of women's health & gender-based medicine·2001
Same author

Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients.

Medicine·2001
Same author

Sjögren's syndrome: a women's health problem.

The Journal of rheumatology. Supplement·2000

Area of Science:

  • Rheumatology
  • Hematology
  • Obstetrics
  • Autoimmunity

Background:

  • Presence of antibodies to negatively charged phospholipids, including lupus anticoagulant and anticardiolipin antibodies, is associated with specific clinical features.
  • These features include a predisposition to arterial and venous thrombosis and fetal wastage in women.
  • This syndrome can occur in patients with established connective tissue disease, undifferentiated disease, or in seemingly healthy individuals, particularly during pregnancy or oral contraceptive use, termed 'subclinical' autoimmune disease.

Purpose of the Study:

  • To highlight the association between antibodies to negatively charged phospholipids and clinical manifestations such as thrombosis and fetal wastage.
  • To address the need for improved diagnostic standardization and controlled studies in managing patients with these antibodies.
  • To emphasize the ongoing challenge in understanding the link between these antibodies, thrombosis, and pregnancy outcomes.

Main Methods:

  • Review of existing literature and clinical observations regarding antibodies to negatively charged phospholipids.
  • Discussion of current treatment recommendations based on uncontrolled studies.
  • Emphasis on the need for standardized laboratory assays, particularly for cardiolipin antibodies.

Main Results:

  • The presence of these antibodies is linked to increased risk of thrombosis and fetal wastage.
  • Subclinical cases exist, but their long-term prognosis regarding overt autoimmune disease requires further investigation.
  • Current treatment guidelines for pregnant patients are based on limited evidence, necessitating controlled trials.

Conclusions:

  • Standardization of antibody testing is essential for accurate diagnosis and management.
  • Well-controlled, age- and parity-matched studies are needed to guide treatment, especially in pregnant women.
  • This research area presents a significant challenge for rheumatologists, hematologists, and obstetricians in linking antibodies, thrombosis, and reproductive health.

Related Experiment Videos